Gilead Sciences (GILD): Officer sold ~$433K
Johanna Mercier, Officer at Gilead Sciences, sold ~$433K of Gilead Sciences shares.
- ~$433K
- Approx. value · 3,000 sh @ $144.23
- 132K
- Holds after · shares reported
- Traded
- Mar 16, 2026
- Filed
- Mar 17, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jan 15, 2026Insider · 2 peopleInsiders: 2 sales (~$746K)
- Jan 20, 2026InsiderDirector sold ~$618K of GILD shares in the open market
- Jan 21, 2026Layoff notice · 4010 Ocean Ranch Blvd Oceanside CA 92056Layoff notice filed in CA: 34 employees
- Jan 23, 2026InsiderCEO sold ~$15.6M of GILD shares in the open market
- Jan 27, 2026CongressDisclosed purchase of GILD — reported range $1,001 - $15,000
- Jan 28, 2026Insider · 1 personInsiders: 2 sales (~$1.4M)
- Feb 5, 20265% stakeFMR LLC reported a passive stake (13G) of 5.3%
- Feb 5, 2026InsiderCEO sold ~$17.3M of GILD shares in the open market
- Feb 10, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 17, 2026Insider · 2 peopleInsiders: 4 sales (~$4.8M)
- Feb 22, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
- Feb 27, 2026Insider · 1 personInsiders: 3 sales (~$1.4M)
- Mar 16, 2026 · this disclosureInsiderOfficer sold ~$433K of GILD shares in the open market
What came next
- Mar 16, 2026InsiderCFO sold ~$433K of GILD shares in the open market
- Mar 25, 2026Layoff notice · 333 Lakeside Drive San Mateo CA 94404Layoff notice filed in CA: 51 employees
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 27, 2026InsiderCEO sold ~$1.37M of GILD shares in the open market
- Apr 15, 2026Insider · 2 peopleInsiders: 2 sales (~$846K)
- Apr 28, 2026Insider · 1 personInsiders: 2 sales (~$1.3M)
- Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- Apr 30, 2026Layoff notice · 800 Bridge Parkway Redwood City CA 94065Layoff notice filed in CA: 108 employees
- May 6, 2026Congress · 1 personMembers of Congress: 2 purchases
- May 7, 2026Company filing · Form 8-K · ResultsReported its results
- May 14, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)
- May 15, 2026Insider · 2 peopleInsiders: 5 sales (~$4.1M)
- May 22, 2026FDAFDA drug approval: Hepcludex
- May 22, 2026Government · Federal Register noticeNotice of Decision Not To Designate Hepatitis Delta Virus Diseases as an Addition to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act
- Jun 1, 2026Insider · 1 personInsiders: 3 sales (~$2.0M)
- Jun 15, 2026Insider · 2 peopleInsiders: 4 sales (~$748K)
- Jun 24, 2026FDAFDA drug approval: Trodelvy
- Jun 24, 2026FDAFDA drug approval: Trodelvy
- Jul 1, 2026Insider · 1 personInsiders: 2 sales (~$1.9M)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Gilead Sciences
For Gilead Sciences, OQRO holds 47 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GILD page.
Other recent filings by Johanna Mercier, Chief Comm & Corp Aff Officer
- SEC Form 4 at Gilead Sciences (GILD)Nov 18, 2026
- SEC Form 4 at Gilead Sciences (GILD)Nov 18, 2026
- SEC Form 4 at Gilead Sciences (GILD)Nov 18, 2026
- SEC Form 4 at Gilead Sciences (GILD)Oct 16, 2026
- SEC Form 4 at Gilead Sciences (GILD)Sep 16, 2026
The full history of Johanna Mercier, Chief Comm & Corp Aff Officer is on the profile page.
How this filing works
Explore the data
Common questions
Which Gilead Sciences (GILD) insider traded, and how much?
Johanna Mercier, Officer at Gilead Sciences, sold ~$433K of Gilead Sciences shares. 3,000 shares at $144.23.
When did it happen, and when was it made public?
Traded: Mar 16, 2026. Filed: Mar 17, 2026. That is 1 day between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Gilead Sciences recently?
For Gilead Sciences, OQRO holds 47 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the GILD page.
Does this mean GILD stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Gilead Sciences
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 144Nov 16, 2026
Everything OQRO holds on this company is on its GILD page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
